Corporate website design for public & pre-ipo companies by VendorGroup®
Your vision
our expertise
Corporate websites for public and pre-ipo companies
Strategic design
Every corporate website is designed around your brand, story, and business goals to create a polished digital presence.
Enterprise hosting
99.99% uptime, layered security, automated backups, CDN delivery, and continuous monitoring keep your website fast and reliable.
Dedicated support
Work directly with the team behind your website for fast, knowledgeable support as your needs evolve.
Brand consistency
Create a seamless experience across your corporate and investor relations websites with consistent design, messaging, and navigation.
Powerful CMS & automation
Manage corporate content, leadership updates, news, careers, and website changes through a CMS built to grow with your business.
Fully managed
From design and development to hosting, updates, and maintenance, we manage the entire website so your team can focus on the business.
Recent corporate website projects
Genvor
Paulex Bio
Paulex Bio is a biopharmaceutical company on a mission to eliminate the root cause of diabetes. Because for us, this is about more than science. It is about the families who wake up every day facing the relentless burden of this disease. That human reality fuels everything we do.
See the Live Site
Lahjavida
Lahjavida Bio is developing targeted cancer therapies that use proprietary Dye-Drug Conjugates (DDCs) to deliver chemotherapy directly to tumors, with the goal of improving efficacy while reducing side effects.
See the Live Site
Stablecoin Development Corporation
NYSE American: SDEV
SDEV is building a publicly traded platform focused on the stablecoin ecosystem, beginning with a strategic position in Sky and expanding into revenue-generating opportunities across digital financial infrastructure.
See the Live Site
EMulate Therapeutics
EMulate Therapeutics is developing wearable digital therapies that use proprietary electromagnetic signals to emulate drug activity and treat cancer, mental health disorders, and pain without pharmaceuticals. oncology, mental health, and pain management.
See the Live Site
CERo Therapeutics
Nasdaq: CERO
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.
See the Live Site
Bevilacqua PLLC
Bevilacqua PLLC is a transactional law firm based in Washington, D.C., specializing in corporate and securities law for both private and publicly held companies. Bevilacqua LLC Their services encompass going public, financing, mergers and acquisitions, and equity crowdfunding, with a notable emphasis on assisting entrepreneurs and company leaders in achieving their business objectives.
See the Live Site
Genvor
OTCQB: GNVR
Genvor is a biotech company developing AI-designed peptide solutions for agriculture. Their products include eco-friendly fungicides, seed traits, and bio-stimulant peptides that boost crop yield, resilience, and food safety without harmful residues. Founded in 2017, Genvor operates with a licensing-first, capital-light model, partnering with leaders like the USDA and Bayer (Golden Ticket awardee in 2024). Headquarters are in Chapel Hill, NC, with corporate filings in Nevada.
See the Live SiteContact
VendorGroup®
